Teacher Retirement System of Texas Buys New Stake in Pediatrix Medical Group, Inc. (NYSE:MD)

Teacher Retirement System of Texas purchased a new stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 193,370 shares of the company's stock, valued at approximately $2,537,000. Teacher Retirement System of Texas owned about 0.23% of Pediatrix Medical Group as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Quest Partners LLC increased its holdings in shares of Pediatrix Medical Group by 25.6% during the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company's stock valued at $35,000 after purchasing an additional 622 shares in the last quarter. Parkside Financial Bank & Trust increased its holdings in Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after buying an additional 1,040 shares in the last quarter. Quarry LP raised its position in shares of Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company's stock worth $55,000 after acquiring an additional 1,662 shares during the period. AlphaQuest LLC boosted its position in Pediatrix Medical Group by 65.9% during the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after purchasing an additional 2,012 shares in the last quarter. Finally, Smartleaf Asset Management LLC grew its stake in Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock valued at $91,000 after acquiring an additional 6,090 shares during the period. 97.71% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. UBS Group boosted their price objective on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a "neutral" rating in a research note on Friday, February 21st. StockNews.com raised Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research note on Wednesday, January 22nd. Truist Financial increased their price objective on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a "hold" rating in a research note on Friday, February 21st. Finally, Macquarie began coverage on shares of Pediatrix Medical Group in a research note on Monday, December 16th. They set an "outperform" rating and a $18.00 target price on the stock. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $17.08.

Pediatrix Medical Group Trading Down 5.8 %

NYSE MD traded down $0.87 on Friday, reaching $14.15. 670,815 shares of the company were exchanged, compared to its average volume of 838,092. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67. The stock has a market capitalization of $1.21 billion, a P/E ratio of -11.79, a price-to-earnings-growth ratio of 1.74 and a beta of 1.49. The business's fifty day moving average price is $14.40 and its 200 day moving average price is $13.69. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The firm had revenue of $502.36 million for the quarter, compared to analysts' expectations of $486.22 million. Analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.